118,917 Shares in Plexus Corp. $PLXS Acquired by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. bought a new position in Plexus Corp. (NASDAQ:PLXS) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 118,917 shares of the technology company’s stock, valued at approximately $35,755,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in shares of Plexus during the 2nd quarter valued at $1,311,631,000. Dimensional Fund Advisors LP lifted its holdings in shares of Plexus by 0.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,373,457 shares of the technology company’s stock valued at $201,903,000 after buying an additional 7,051 shares during the period. State Street Corp boosted its stake in Plexus by 2.3% during the second quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock valued at $143,361,000 after buying an additional 24,115 shares in the last quarter. Geode Capital Management LLC boosted its stake in Plexus by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 672,614 shares of the technology company’s stock valued at $98,890,000 after buying an additional 4,054 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in Plexus by 5.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 446,705 shares of the technology company’s stock worth $65,666,000 after acquiring an additional 24,441 shares during the period. 94.45% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on PLXS shares. Needham & Company LLC reissued a “buy” rating and issued a $310.00 price target on shares of Plexus in a report on Friday, August 14th. Wall Street Zen upgraded shares of Plexus from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Weiss Ratings lowered shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, August 11th. Stifel Nicolaus upped their price target on Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Finally, Raymond James Financial reissued an “outperform” rating and set a $275.00 price objective on shares of Plexus in a research note on Thursday, April 30th. One analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $273.00.

Plexus Stock Performance

Plexus stock opened at $237.61 on Tuesday. Plexus Corp. has a fifty-two week low of $132.03 and a fifty-two week high of $307.06. The firm’s 50 day simple moving average is $267.90 and its 200-day simple moving average is $243.10. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72. The company has a market cap of $6.36 billion, a P/E ratio of 35.05 and a beta of 0.90.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 EPS for the quarter, topping analysts’ consensus estimates of $2.13 by $0.19. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The firm had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.23 billion. During the same quarter last year, the business posted $1.64 EPS. The company’s revenue was up 28.2% on a year-over-year basis. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, equities research analysts predict that Plexus Corp. will post 7.11 EPS for the current year.

Insider Transactions at Plexus

In related news, Director Michael V. Schrock sold 4,000 shares of the stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total value of $1,100,000.00. Following the completion of the sale, the director directly owned 40,329 shares of the company’s stock, valued at approximately $11,090,475. This represents a 9.02% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael J. Running sold 510 shares of the firm’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $272.17, for a total value of $138,806.70. Following the sale, the insider owned 665 shares of the company’s stock, valued at $180,993.05. The trade was a 43.40% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 9,510 shares of company stock valued at $2,622,497 over the last quarter. Company insiders own 1.78% of the company’s stock.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.